ロード中…
The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
We analyzed the correlation between survival and antitumor effect evaluated by RECIST in advanced NSCLC patients with chemotherapy plus target therapy or not as first-line treatment, to examine the applicability of RECIST in this population. The patients were screened from 4 clinical trials (12621,...
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Online 論文 テキスト |
| 言語: | English |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286759/ https://www.ncbi.nlm.nih.gov/pubmed/25567662 http://dx.doi.org/10.1038/srep07683 |